Created at Source Raw Value Validated value
Jan. 30, 2021, 12:45 a.m. oms

(1) Japanese male or female patients aged 20 or above at the time of obtaining informed consent(2) Patients in which SARS-CoV-2 was detected from the upper and lower respiratory tract specimens using polymerase chain reaction (PCR) or loop-mediated isothermal amplification, or those who were positive for the antigen at least 3 days before obtaining the informed consent.(3) Patients who have been provided with complete information about the contents of the informed consent form and other study-related details, and who voluntarily sign the informed consent form to participate in the study after having understood the study content.

(1) Japanese male or female patients aged 20 or above at the time of obtaining informed consent(2) Patients in which SARS-CoV-2 was detected from the upper and lower respiratory tract specimens using polymerase chain reaction (PCR) or loop-mediated isothermal amplification, or those who were positive for the antigen at least 3 days before obtaining the informed consent.(3) Patients who have been provided with complete information about the contents of the informed consent form and other study-related details, and who voluntarily sign the informed consent form to participate in the study after having understood the study content.

Oct. 26, 2020, 8:29 a.m. oms

(1) Japanese male or female patients aged 20 or above at the time of informed consent(2) Patients who had SARS-CoV-2 detected from upper and lower respiratory specimens by PCR or LAMP testing within 3 days before informed consent(3) Patients who have been given full explanation about the contents of the informed consent form and other study-related details, understood the study content, and voluntarily signed the informed consent to participate in the study

(1) Japanese male or female patients aged 20 or above at the time of informed consent(2) Patients who had SARS-CoV-2 detected from upper and lower respiratory specimens by PCR or LAMP testing within 3 days before informed consent(3) Patients who have been given full explanation about the contents of the informed consent form and other study-related details, understood the study content, and voluntarily signed the informed consent to participate in the study